| emtricitabine/tenofovir disoproxil fumarate / Generic mfg. |
TARCoV, ChiCTR2000029468: A real-world study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19) |
|
|
| Not yet recruiting | N/A | 120 | China | Lopinavir/litonavir (LPV/r)+ emtritabine (FTC)/ Tenofovir alafenamide Fumarate tablets (TAF) in combination ;LPV/r | Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences; Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Department of science and technology of sichuan province (2020YFS0006) | novel coronavirus pneumonia (COVID-19) | | | | |
NCT04898699: IPrEP Men's Study: Expanding the Reach of Prevention for Men in Kisumu, Kenya |
|
|
| Not yet recruiting | N/A | 120 | NA | UrSure Rapid Urine Tenofovir Test, OraQuick Rapid HIV Self-test kit, Tenofovir (300mg)/Emtricitabine(200mg) [Truvada®], 2-way text message reminders, HIV risk-reduction counseling | Columbia University, Impact Research & Development Organization, Research Foundation for Mental Hygiene, Inc. | HIV | 03/22 | 03/22 | | |
NCT04583267: HIV Pre-exposure Prophylaxis Implementation Study in South Korea |
|
|
| Recruiting | N/A | 200 | RoW | tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration | Yonsei University | HIV Infections | 12/22 | 12/22 | | |
| Completed | N/A | 17 | US | Suboxone, Buprenorphine Naloxone, Truvada, Pre-Exposure Prophylaxis (PrEP), Mavyret, Hepatitis C treatment | Duke University, Center for AIDS Research (CFAR), National Institute of Allergy and Infectious Diseases (NIAID) | Opioid Use, Opioid Use Disorder, Risk Reduction, Hiv, Hepatitis C | 03/23 | 03/23 | | |
ChiCTR2200059994: A clinical research for Biktarvy following potential exposure to HIV-1 |
|
|
| Not yet recruiting | N/A | 100 | | Biktarvy is taken orally once a day. ;TDF+FTC+DTG/RAL | Guiyang public health treatment center; Guiyang public health treatment center, self-finacing | HIV/AIDS | | | | |
INSIGHT, NCT05746065: A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women |
|
|
| Completed | N/A | 3087 | RoW | PrEP, Truvada | University of Washington, Bill and Melinda Gates Foundation | HIV Infections | 08/23 | 08/23 | | |
NCT04778514: A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Completed | N/A | 30 | RoW | Dual Prevention Pill, DPP, PrEP and combined oral contraceptive (COC) as two separate tablets, Truvada, Zinnia F | Population Council, University of Zimbabwe | HIV Infections, Contraception | 09/23 | 09/23 | | |
NCT04593680: Assessment of Drug-drug Interactions Between Masculinizing Hormone Therapy and Antiretroviral Agents Concomitantly for Pre-exposure Prophylaxis Among Transgender Men |
|
|
| Recruiting | N/A | 40 | RoW | Emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg (F/TDF) and emtricitabine 200 mg/tenofovir alafenamide 25 mg (F/TAF) | Thai Red Cross AIDS Research Centre | Drug Interaction | 10/23 | 10/25 | | |
NCT04778527: A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention |
|
|
| Active, not recruiting | N/A | 96 | RoW | Dual Prevention Pill, DPP, PrEP tablet and a COC as two separate tablets, Truvada, Zinnia F | Population Council | HIV Infections | 01/24 | 01/24 | | |
| Recruiting | N/A | 621 | RoW | Initiating daily oral PrEP during pregnancy, Tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) or lamivudine (3TC) (FTC/TDF or TDF/3TC), Already using daily oral PrEP at the time of pregnancy diagnosis, Initiating injectable PrEP during pregnancy, CAB-LA, Already using injectable PrEP (CAB-LA) at the time of pregnancy diagnosis | University of North Carolina, Chapel Hill, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), United States President's Emergency Plan for AIDS Relief, Ministry of Health, Malawi | Pre-exposure Prophylaxis, HIV Prevention, Pregnancy Related | 12/26 | 12/27 | | |
| Recruiting | N/A | 3257 | Europe | PrEP with Truvada®, Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) | ANRS, Emerging Infectious Diseases | HIV Infections | 05/24 | 10/24 | | |
ChiCTR2200061677: Impact of different antiretroviral therapy (ART) regimens on lipid metabolism in people living with HIV |
|
|
| Not yet recruiting | N/A | 180 | | EVG/c/TAF/FTC ;B/FTC/TAF ;DTG/3TC ;DTG/3TC/TDF ;DTG/FTC/TDF ;TDF/3TC/EFV | The First Affiliated Hospital, College of Medicine, Zhejiang University; The First Affiliated Hospital, College of Medicine, Zhejiang University, National Special Research Program for Important Infectious Diseases | AIDS | | | | |
| Recruiting | N/A | 50 | US | LA-CAB, Apretude, TDF/FTC, Truvada | Orlando Immunology Center | HIV Prevention | 09/24 | 09/24 | | |
BMS02, NCT04862975: Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana |
|
|
| Recruiting | N/A | 200 | RoW | Dolutegravir, Dolutegravir Sodium, DTG, Lamivudine, 3TC, Emtricitabine, FTC, Tenofovir Disoproxil Fumarate, Tenofovir DF, TDF | Duke University, The Emmes Company, LLC | Lactating Women on Select DOI, Breastmilk Fed Infants of Mothers on Select DOI, HIV Infections | 12/24 | 12/24 | | |
Prep-RN, NCT06030557: PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP) |
|
|
| Recruiting | N/A | 210 | US | Truvada, Descovy | CAN Community Health | Hiv Prevention, Pre-Exposure Prophylaxis (PrEP) | 07/25 | 07/25 | | |
